A Year After Cancer Milestone, Novartis’s Barrett Talks Next Steps

(Bloomberg) -- A Novartis AG cancer treatment made history on Aug. 30, 2017, becoming the first of an innovative approach known as CAR-Ts to be approved in the U.S. The breakthrough heralded a new ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.